Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Pooled analysis from randomized phase 2 and 3 studies

Johannes Ettl^*, Seock Ah Im, Jungsil Ro, Norikazu Masuda, Marco Colleoni, Patrick Schnell, Eustratios Bananis, Dongrui R. Lu, Massimo Cristofanilli, Hope S. Rugo, Richard S. Finn

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

2 results
- Title
- Start date(ascending)

Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies
Ettl, J. (Creator), Im, S. (Contributor), Ro, J. (Contributor), Masuda, N. (Contributor), Colleoni, M. (Creator), Schnell, P. (Creator), Bananis, E. (Contributor), Lu, D. R. (Contributor), Cristofanilli, M. (Creator), Rugo, H. S. (Creator) & Finn, R. S. (Creator), figshare, 2020
DOI: 10.6084/m9.figshare.c.4892817, https://springernature.figshare.com/collections/Hematologic_adverse_events_following_palbociclib_dose_reduction_in_patients_with_hormone_receptor_positive_human_epidermal_growth_factor_receptor_2_negative_advanced_breast_cancer_pooled_analysis_from_randomized_phase_2_and_3_studies/4892817
Dataset
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies
Ettl, J. (Creator), Im, S. (Contributor), Ro, J. (Contributor), Masuda, N. (Contributor), Colleoni, M. (Creator), Schnell, P. (Creator), Bananis, E. (Contributor), Lu, D. R. (Contributor), Cristofanilli, M. (Creator), Rugo, H. S. (Creator) & Finn, R. S. (Creator), figshare, 2020
DOI: 10.6084/m9.figshare.c.4892817.v1, https://springernature.figshare.com/collections/Hematologic_adverse_events_following_palbociclib_dose_reduction_in_patients_with_hormone_receptor_positive_human_epidermal_growth_factor_receptor_2_negative_advanced_breast_cancer_pooled_analysis_from_randomized_phase_2_and_3_studies/4892817/1
Dataset